These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 10331109

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M, Vandoolaeghe E, Desnyder R.
    J Affect Disord; 1996 Dec 16; 41(3):201-10. PubMed ID: 8988452
    [Abstract] [Full Text] [Related]

  • 6. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB, Berman RM, Sanacora G, Anand A, Lynch-Colonese K, Charney DS.
    J Clin Psychiatry; 2004 Feb 16; 65(2):238-43. PubMed ID: 15003079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 16; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pindolol augmentation enhances response outcomes in first depressive episodes.
    Portella MJ, de Diego-Adeliño J, Puigdemont D, Pérez-Egea R, Alvarez E, Artigas F, Pérez V.
    Eur Neuropsychopharmacol; 2009 Jul 16; 19(7):516-9. PubMed ID: 19419845
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
    Heiligenstein JH, Tollefson GD, Faries DE.
    J Affect Disord; 1994 Mar 16; 30(3):163-73. PubMed ID: 8006243
    [Abstract] [Full Text] [Related]

  • 17. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar 16; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 18. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients.
    Muijen M, Roy D, Silverstone T, Mehmet A, Christie M.
    Acta Psychiatr Scand; 1988 Sep 16; 78(3):384-90. PubMed ID: 3057817
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.